Home Cart Sign in  
Chemical Structure| 151767-02-1 Chemical Structure| 151767-02-1

Structure of Montelukast Sodium
CAS No.: 151767-02-1

Chemical Structure| 151767-02-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Montelukast Sodium is a potent, selective and competitive LTR1 antagonist with IC50 value < 5 nM, possesssing anti-inflammatory and bronchodilating activities.

Synonyms: MK0476; Montelukast(sodium salt); MK-476

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Montelukast Sodium

CAS No. :151767-02-1
Formula : C35H35ClNNaO3S
M.W : 608.17
SMILES Code : CC(O)(C)C1=CC=CC=C1CC[C@H](C2=CC=CC(/C=C/C3=NC4=C(C=CC(Cl)=C4)C=C3)=C2)SCC5(CC5)CC([O-])=O.[Na+]
Synonyms :
MK0476; Montelukast(sodium salt); MK-476
MDL No. :MFCD00931431
InChI Key :LBFBRXGCXUHRJY-HKHDRNBDSA-M
Pubchem ID :23663996

Safety of Montelukast Sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • LTR

In Vitro:

Cell Line
Concentration Treated Time Description References
Lung ILC2 cells 10^-6 M and 10^-8 M 6 hours To evaluate the effect of montelukast on LTD4-induced IL-4, IL-5, and IL-13 production by ILC2. Results showed that LTD4 significantly induced IL-4, IL-5, and IL-13 production by ILC2, and montelukast pretreatment blocked this effect. PMC3704056

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Mouse asthma model 1 mg/kg Subcutaneous osmotic pump From Day 73 to Day 163, lasting 90 days To evaluate the reversal effect of Montelukast on established airway remodeling. Results showed that Montelukast significantly reduced airway smooth muscle layer thickening and subepithelial collagen deposition/fibrosis. PMC2662952
BALB/c mice RSV infection model 30 mg/kg Oral Once daily, from 1 day before primary infection to day 6 after infection To evaluate the effects of montelukast on RSV-induced AHR and airway inflammation. Results showed that MK administered during primary infection reduced AHR and airway inflammation and increased IFN-γ production. PMC2937239
Mice Laser-induced choroidal neovascularization model 1 mg/kg Intraperitoneal injection Daily from D0 to D6 Montelukast inhibits CYP2C8, and combined with flunarizine further enhanced CNV suppression via tumor necrosis factor-α suppression. PMC9535696

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02110654 Sinusitis Nas... More >>al Polyps Asthma Less << Phase 4 Unknown June 2016 China, Guangdong ... More >> the first affiliated hospital, Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: Fenghong Chen, doctor    02086013560170816    chfhong@mail.sysu.edu.cn    Principal Investigator: jianbo Shi, doctor Less <<
NCT00504946 Asthma Phase 3 Completed - Poland ... More >> Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland Lodz, Poland, 93-513 Less <<
NCT00398151 Asthma Phase 3 Completed - -
NCT00394160 Bronchiolitis Phase 2 Completed - -
NCT02720081 Asthma Phase 2 Completed - -
NCT00979901 - Completed - -
NCT01424124 Asthma Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00756418 Asthma Phase 4 Completed - -
NCT02720081 - Completed - -
NCT02104674 Asthma Phase 3 Completed - -
NCT00551382 Upper Respiratory Tract Infect... More >>ion Less << Phase 3 Unknown June 2010 Israel ... More >> Kupat Cholim Clalit Recruiting Lod, Israel Contact: Al Garushi          Principal Investigator: Al Garushi, MD          Kupat Cholim Clalit Recruiting Ramla, Israel Principal Investigator: Zachi Lotem          Assaf Harofeh Recruiting Zerifin, Israel, 70300 Contact: Berkovitch    97289779152       Principal Investigator: Mati Berkovitch, MD Less <<
NCT02341573 Childhood Asthma Not Applicable Completed - China, Shanghai ... More >> Department of Chinese Traditional Medicine; Children Hospital of Fudan University Shanghai, Shanghai, China, 201102 Less <<
NCT00492102 Bronchopulmonary Dysplasia Phase 1 Completed - United States, Ohio ... More >> Good Samaritan Hospital Cincinnati, Ohio, United States, 45220-2489 Less <<
NCT03369119 Acute Asthma ... More >>Acute Wheezy Bronchitis Less << Phase 4 Completed - Turkey ... More >> Kecioren Education and Training Hospital Ankara, Keçiören, Turkey, 06380 Less <<
NCT00273013 Asthma Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site London, United Kingdom, SE1 9RT Less <<
NCT00943683 - Completed - -
NCT00912171 Obstructive Sleep Apnea Syndro... More >>me Less << Phase 4 Completed - Italy ... More >> Department if Pediatrics, Hospital S. Orsola-Malpighi , University of Bologna Bologna, Italy, 40138 Less <<
NCT00943683 Asthma Not Applicable Completed - -
NCT00913328 Asthma Phase 4 Completed - -
NCT00968149 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT00968149 - Completed - -
NCT00979901 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT00511316 Eosinophilic Esophagitis Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00637611 Seasonal Allergic Rhinitis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00092144 Asthma Phase 3 Completed - -
NCT01140048 - Completed - -
NCT01140048 - Completed - -
NCT01770899 Status Asthmaticus Not Applicable Unknown - United States, Illinois ... More >> Advocate Children's Hospital Oak Lawn Recruiting Oak Lawn, Illinois, United States, 60453 Principal Investigator: Corrie Fletcher, DO Less <<
NCT00273689 Exercise Induced Bronchospasm Phase 4 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT00442559 Asthma Allerg... More >>ic Rhinitis Less << Phase 4 Completed - -
NCT00442559 - Completed - -
NCT00524693 Bronchiolitis Not Applicable Completed - -
NCT00488176 Seasonal Allergic Rhinitis Phase 4 Unknown December 2013 Poland ... More >> Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland Recruiting Lodz, Poland, 93-513 Contact: Violetta Ścibiorek, MD    00 48 42 689 59 72    alergol@kopernik.lodz.pl    Principal Investigator: Iwona Stelmach, MD, PhD, Prof Less <<
NCT01943942 Asthma Phase 1 Completed - -
NCT01863654 Asthma Phase 1 Completed - -
NCT00289874 Asthma Phase 3 Completed - -
NCT00960141 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT00289874 - Completed - -
NCT00968201 Asthma Phase 3 Completed - -
NCT00351364 Coronary Artery Disease|Acute ... More >>Coronary Syndrome Less << PHASE4 TERMINATED 2025-07-10 Foothills Medical Center, Calg... More >>ary, Alberta, T2N 2T9, Canada Less <<
NCT00960141 - Completed - -
NCT00968201 - Completed - -
NCT00337675 Asthma Phase 3 Completed - -
NCT00943397 Asthma Phase 3 Completed - -
NCT01852812 Perennial Allergic Rhinitis Phase 3 Completed - -
NCT00943397 - Completed - -
NCT00284856 Asthma Phase 3 Completed - -
NCT00337675 - Completed - -
NCT00284856 - Completed - -
NCT01621386 Asthma Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT00092105 Asthma, Bronchial ... More >> Rhinitis, Allergic, Perennial Less << Phase 3 Completed - -
NCT00656058 - Completed - -
NCT00656058 Bronchiolitis Obliterans ... More >> Chronic Graft Versus Host Disease Leukotriene Montelukast Stem Cell Transplant Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00770900 Asthma Phase 4 Completed - -
NCT00534976 Exercise-induced Bronchoconstr... More >>iction (EIB) Less << Phase 4 Completed - -
NCT01086527 Asthma Phase 1 Unknown September 2014 United States, Florida ... More >> Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Mary K Warde, RN    904-697-3176    mwarde@nemours.org    Principal Investigator: Edward B Mougey, Ph.D.          Sub-Investigator: John J Lima, PharmD          Sub-Investigator: Jason E Lang, MD Less <<
NCT00534976 - Completed - -
NCT01673620 - Completed - -
NCT01673620 Allergic Rhinitis Phase 3 Completed - -
NCT00863317 - Completed - -
NCT00394069 Bronchiolitis Phase 2 Completed - -
NCT01852812 - Completed - -
NCT00540839 Asthma, Bronchial Phase 3 Withdrawn(Based on input from ... More >>regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes.) Less << - -
NCT00700661 Asthma Phase 3 Completed - -
NCT00380705 Asthma Rhinit... More >>is Allergic Less << Phase 4 Completed - -
NCT00117338 - Completed - -
NCT00445107 Asthma Phase 3 Completed - -
NCT00863317 Bronchiolitis Not Applicable Completed - United States, Wisconsin ... More >> Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00076973 Bronchiolitis Phase 3 Completed - -
NCT00664937 Asthma, Exercise-induced Phase 1 Completed - -
NCT02658422 Respiratory Disorders ... More >> Asthma and Rhinitis Less << Phase 1 Completed - India ... More >> GSK Investigational Site Telangana, India, 500 013 Less <<
NCT00406094 Rhinitis Phase 4 Unknown December 2009 United States, Ohio ... More >> Bernstein Allergy Group Recruiting Cincinnati, Ohio, United States, 45231 Contact: Jonathan A Bernstein, MD    513-931-0775    bernsteincrc@fuse.net    Principal Investigator: Jonathan A Bernstein, MD Less <<
NCT00832455 - Completed - -
NCT00117338 Asthma Phase 3 Completed - -
NCT01659892 Asthma Early Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT01659905 Asthma Early Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00545324 Asthma Phase 4 Completed - -
NCT01659918 Asthma Early Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00446186 Rhinitis Allergic Phase 2 Completed - -
NCT00489346 Asthma, Bronchial Phase 3 Completed - -
NCT00638118 Allergic Rhinitis Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00832455 Asthma Phase 4 Completed - -
NCT00636207 Asthma Phase 1 Completed - -
NCT00739297 Chronic Asthma Phase 1 Completed - -
NCT01659931 Asthma Early Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT01491503 Healthy Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT00442338 - Completed - -
NCT00636207 - Completed - -
NCT01857063 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT00442338 Asthma Phase 3 Completed - -
NCT01857063 - Completed - -
NCT00911547 - Completed - -
NCT00739297 - Completed - -
NCT00127647 Rhinitis, Allergic, Seasonal Phase 3 Completed - -
NCT00911547 Asthma Phase 3 Completed - -
NCT00641472 Asthma Phase 4 Completed - -
NCT01307462 Bronchiolitis Obliterans Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic - Scottsdale Scottsdale, Arizona, United States, 85054 United States, California Stanford University Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Maryland National Cancer Institute Experimental Transplantation & Immunology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00092989 Asthma Phase 3 Completed - -
NCT00229970 Asthma Phase 3 Completed - -
NCT00157937 Asthma Allerg... More >>ic Rhinitis Less << Phase 4 Completed - -
NCT00140881 Asthma Phase 4 Completed - -
NCT00162864 Asthma COPD Phase 3 Completed - United States, Oregon ... More >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Less <<
NCT01307462 - Completed - -
NCT00140946 Asthma Phase 4 Completed - -
NCT02479854 Healthy Phase 1 Completed - Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less <<
NCT01651481 Rhinitis Phase 1 Completed - Korea, Republic of ... More >> Samsung medical center Seoul, Korea, Republic of Less <<
NCT01931501 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar, Gujarat, India, 382428 Less <<
NCT01931514 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar, Gujarat, India, 382428 Less <<
NCT01928069 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar,, Gujarat,, India, 382428 Less <<
NCT02480049 Healthy Phase 1 Completed - Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less <<
NCT01928056 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd. Village Bhat, Gandhinagar, Gujarat, India, 382428 Less <<
NCT01717625 Premature Birth ... More >> Infant, Very Low Birth Weight Bronchopulmonary Dysplasia Less << Phase 2 Completed - Korea, Republic of ... More >> Ajou university medical center Suwon, Woncheon-dong, Yeongtong-gu,, Korea, Republic of, 443-721 Less <<
NCT00229970 - Completed - -
NCT01640535 Perennial Allergic Rhinitis Phase 3 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 Less <<
NCT00771160 Rhinitis, Allergic Phase 3 Completed - -
NCT00545844 - Completed - -
NCT02029313 Asthma and Allergic Rhinitis Phase 1 Completed - Korea, Republic of ... More >> Inha University Hospital Incheon, Junggu, Korea, Republic of Less <<
NCT00755794 Asthma Phase 3 Completed - -
NCT00545844 Asthma Phase 4 Completed - -
NCT02322671 Respiratory Disorders Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, India, 500 013 Less <<
NCT01691456 Healthy Phase 1 Completed - India ... More >> AXIS Clinicals Limited, Hyderabad, Andhra Pradesh, India, 500 049 Less <<
NCT01674504 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less <<
NCT01671709 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less <<
NCT01691469 Healthy Phase 1 Completed - India ... More >> AXIS Clinicals Limited, Hyderabad, Andhra Pradesh, India, 500 049 Less <<
NCT02494466 Airway Reactivity Phase 4 Completed - Turkey ... More >> Gulsah Karaoren Istanbul, Turkey Less <<
NCT01671722 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less <<
NCT01674517 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, India, 500 037 Less <<
NCT04474327 Neonatal Sepsis PHASE1 COMPLETED 2021-02-10 Mansoura University Childran H... More >>ospital, Mansoura, Dakahlia, 35116, Egypt Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.22mL

1.64mL

0.82mL

16.44mL

3.29mL

1.64mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories